Alphanate® AHF/VWF complex

Hemophilia A

Alphanate®, Antihemophilic Factor/von Willebrand Factor Complex (Human), is indicated for the control and prevention of bleeding in patients with Factor VIII (FVIII) deficiency due to hemophilia A.

von Willebrand Disease

Alphanate® is indicated for surgical and/or invasive procedures in adult and pediatric patients with von Willebrand Disease (VWD) in whom desmopressin (DDAVP®) is either ineffective or contraindicated. It is not indicated for patients with severe VWD (Type 3) undergoing major surgery.

For indications, dosing and other information, please refer to the prescribing information.

Alphanate® AHF/VWF Complex ‐ Grifols

Size:
250 iu, 5 mL vial
NDC #:
68516-4601-01
Download:
PI
Size:
500 iu, 5 mL vial
NDC #:
68516-4602-01
Download:
PI
Size:
1000 iu, 10 mL vial
NDC #:
68516-4603-02
Download:
PI
Size:
1500 iu, 10 mL vial
NDC #:
68516-4604-02
Download:
PI
Size:
2000 iu, 10 mL vial
NDC #:
68516-4609-02
Download:
PI